Glenmark Pharmaceuticals(Search results - 2)
India21, Jun 2020, 5:56 PM
Coronavirus: Glenmark launches drug Favipiravir to treat mild to moderate COVID-19 cases
In a major coronavirus treatment breakthrough, Glenmark Pharmaceuticals' FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19.
India26, May 2020, 12:41 PM
India's Glenmark pharmaceuticals to study potential COVID-19 drug combination
The study will look to enrol 158 hospitalised patients of moderate COVID-19 in India, the company added.